Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The genomics market was valued at USD 50.44 Billion in 2025. It is poised to grow at a CAGR of 10.20% during the forecast period of 2026-2035, and reach USD 133.23 Billion by 2035. The market growth is supported by the rapid expansion of next-generation sequencing (NGS) adoption, growing precision medicine and oncology applications, expanding multiomics workflows integrating genomics with proteomics, and increasing strategic acquisitions and partnerships among leading sequencing instrument and reagent manufacturers.
Latest News on the Genomics Market (2026)
April 2026: Illumina Partners with D3b on Pediatric Genomic Data Initiative
According to Reuters, Illumina announced on April 14 a data partnership with the Center for Data-Driven Discovery in Biomedicine to analyze 100,000 whole genomes from pediatric patients. The initiative supports one of the largest unified genomic datasets ever assembled, reinforcing North America's leadership in genomic data infrastructure and accelerating precision medicine applications across rare disease and cancer research.
March 2026: Illumina Advances Preventive Genomics Through Strategic Veritas Genetics Collaboration
As reported by Fierce Pharma, Illumina and Veritas Genetics formed a consortium on March 16 to integrate whole-genome sequencing into health insurance plans in the United States and other global markets. The collaboration combines clinical-grade sequencing with advanced informatics, aiming to expand population-scale genomics adoption and shift healthcare delivery from reactive treatment toward proactive prevention frameworks.
Key Market Trends and Insights
- By offering, the product segment held the largest share of the market in the historical period.
- Based on the application, the functional genomics accounted for almost 32% market share in the historical period.
- By end user, the pharmaceutical and biotechnology companies held nearly 54% market share in the historical period.
Market Size and Forecast
- Market Size (2025): USD 50.44 Billion
- Projected Market Size (2035): USD 133.23 Billion
- CAGR (2026-2035): 10.20%
- Largest Market in 2025: North America
Compound Annual Growth Rate
10.2%
Value in USD Billion
2026-2035
Genomics Market Overview
Genomics is playing an increasingly important role in precision medicine, disease diagnostics, drug discovery, and advanced biological research. The market reached a value of approximately USD 50.44 Billion in 2025, and is anticipated to expand strongly, supported by the rapid expansion of next-generation sequencing adoption, growing precision medicine and oncology applications, and expanding multiomics workflows integrating genomics with proteomics. Continued investment by leading sequencing manufacturers in clinical-grade platforms and integrated data analytics is reinforcing market growth. Continued integration with personalized medicine and oncology diagnostics workflows is further accelerating expansion across pharmaceutical, hospital, and academic research segments globally.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Genomics Market Segmentation
Market Breakup by Offering
- Products
- Instruments/Systems
- Software
- Consumables and Reagents
- Services
- NGS-based Services
- Core Genomics Services
- Biomarker Translation Services
- Computational Services
- Others
The market is segmented by offering into products and services. The products are expected to lead the segment due to high recurring demand for next-generation sequencing consumables, reagents, and instrument upgrades, while services are growing rapidly as pharmaceutical companies and clinical labs outsource sequencing workflows. The integration with next-generation sequencing reagents and informatics platforms is reinforcing this segmentation growth
Market Breakup by Technology
- Sequencing
- PCR
- Flow Cytometry
- Microarrays
- Others
Technology coverage spans sequencing, polymerase chain reaction (PCR), flow cytometry, microarrays, and other platforms. Sequencing is expected to dominate as next-generation and third-generation sequencing platforms continue to expand across clinical, research, and diagnostic applications, while PCR remains anchored in infectious disease and oncology diagnostics. Continued investment in in vitro diagnostics reinforces the role of sequencing-based platforms.
Market Breakup by Application
- Drug Discovery and Development
- Functional Genomics
- Biomarker Discovery
- Pathway Analysis
- Epigenomics
- Diagnostics
- Infectious Diseases
- Reproductive Health
- Others
Applications span drug discovery and development, functional genomics, biomarker discovery, pathway analysis, epigenomics, and diagnostics. The growing integration of genomics across research, pharmaceutical development, and clinical diagnostics is supporting broader adoption of advanced sequencing technologies and bioinformatics tools. Increasing use of next-generation sequencing in disease profiling, personalized medicine, and molecular research is further strengthening the role of genomics across the healthcare and life sciences industries globally.
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Others
End users include pharmaceutical and biotechnology companies, hospitals and clinics, diagnostic laboratories, academic and research institutes, and other end users. Pharmaceutical and biotechnology companies are expected to lead due to high spending on genomics-driven drug discovery, while diagnostic laboratories and hospitals are growing rapidly with clinical NGS adoption. Continued growth of clinical laboratory services is reinforcing demand for end-to-end sequencing workflows.
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Regional coverage spans North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate due to mature genomics infrastructure, strong National Institutes of Health (NIH) funding, and concentration of leading instruments and reagent manufacturers. Asia Pacific is anticipated to expand rapidly as China, Japan, and India accelerate national genomics programs.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Genomics Market Growth Analysis and Key Influencers
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Rapid integration of next-generation sequencing adoption across research and clinical settings |
In February 2026, Illumina launched TruPath Genome with advanced on-flow cell library preparation technology at AGBT 2026. |
|
Market Restraints |
High cost of sequencing instruments and complex data analysis requirements |
Regulatory compliance challenges and export-control restrictions have historically affected sequencing instrument availability across selected global markets. |
|
Market Opportunities |
Increasing expansion of multiomics platforms integrating genomics with proteomics |
In January 2026, Illumina acquired SomaLogic for USD 350 million, expanding its multiomics portfolio with SomaScan proteomics technology. |
Genomics Market Dynamics
This section analyzes key factors influencing market growth, including rapid advancements in next-generation sequencing technologies, increasing integration of multiomics platforms, and rising adoption of precision medicine.
Genomics Market Drivers
Rapid NGS Adoption and Multiomics Expansion to Boost the Market Value
The market is witnessing strong growth driven by the rapid expansion of next-generation sequencing adoption and the broadening of multiomics workflows across the market. For instance, in February 2026, Illumina launched TruPath Genome at the AGBT 2026 conference, a whole-genome workflow that eliminates traditional library preparation through on-flow cell library preparation with patterned flow cell technology. The expanding next-generation sequencing (NGS) is further supporting sequencing adoption across research and diagnostic environments globally.
Genomics Market Restraints
High Instrument Costs and Regulatory Complexity Limiting Market Demand
The high cost of sequencing instruments, complex bioinformatics requirements, and heterogeneous regulatory frameworks for clinical NGS-based diagnostics across the US Food and Drug Administration, European Medicines Agency, and other jurisdictions remain notable restraints. Trade restrictions and export-control regulations have historically affected sequencing instrument availability in selected markets. The evolving genomics industry outlook continues to reflect operational challenges associated with compliance, affordability, and laboratory infrastructure expansion globally.
Genomics Market Opportunities
Multiomics Acquisitions and AI-Driven Drug Discovery are Likely to Enhance the Market Landscape
The expansion of multiomics platforms integrating genomics with proteomics and the introduction of AI-enabled drug discovery initiatives are creating significant growth opportunities. For instance, in January 2026, Illumina completed its USD 350 million acquisition of SomaLogic, expanding its multiomics portfolio with SomaScan proteomics technology. The company also launched the Billion Cell Atlas initiative in collaboration with AstraZeneca, Merck, and Eli Lilly to accelerate AI-enabled drug discovery. These developments are further supporting innovation in precision medicine, translational research, and targeted therapeutics.
Genomics Market Trends
Expansion of AI-Driven Genomics Facilities is Likely to Boost Market Growth
The increasing expansion of AI-powered genomics laboratories and precision medicine infrastructure is emerging as a significant trend in the genomics market. For instance, in February 2026, the Austin Economic Development Department announced that South Korean genomics company 3billion would establish its first North American genomic testing laboratory in Austin, Texas, supported by an USD 8.1 million investment. The facility is expected to strengthen AI-driven rare disease diagnostics and genomic testing capacity, thereby supporting long-term genomics market growth globally..
Genomics Market Share
Functional Genomics is Likely to Lead the Market Segment by Application
The market is segmented by application into drug discovery and development, functional genomics, biomarker discovery, pathway analysis, epigenomics, and diagnostics. Among these, the functional genomics segment is expected to lead the market, accounting for nearly 32% of the market share in the historical period, owing to the increasing use of gene expression profiling, genome mapping, and CRISPR-based studies in precision medicine and translational research. The growing investments in genomics research and sequencing technologies are expected to continue supporting segment expansion.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Genomics Market Analysis by Region
Among all the regions, North America is likely to lead the market, supported by established genomics infrastructure, strong funding, and the presence of leading manufacturers across the region. The United States is witnessing substantial investment in genomic diagnostics, pharmaceutical collaborations, and precision medicine initiatives supporting broader technology adoption. The expanding oncology genomics landscape is further accelerating demand for advanced sequencing technologies, companion diagnostics, and biomarker-driven cancer treatment strategies across healthcare and research institutions throughout the forecast period.
Leading Players in the Genomics Market
Illumina, Inc.
Illumina, Inc., headquartered in San Diego, California, United States, was founded in 1998 and is one of the global leaders in DNA sequencing and array-based technologies. Its product portfolio includes the NovaSeq X Series, NextSeq, MiSeq, and iSeq sequencing platforms, the DRAGEN bioinformatics software, and the recently launched TruPath Genome whole-genome workflow. Following its acquisition of SomaLogic, in January 2026, Illumina has expanded into proteomics and multiomics.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, United States, was founded in 2006 through the merger of Thermo Electron and Fisher Scientific. Its genomics portfolio spans the Invitrogen reagents and Applied Biosystems consumables, and the SeqStudio Genetic Analyzer. The company supports drug discovery, clinical diagnostics, and applied markets globally with end-to-end genomics workflows.
Danaher Corporation
Danaher Corporation, headquartered in Washington, D.C., United States, was founded in 1969 and operates leading life sciences and diagnostics businesses. Its genomics research and molecular diagnostics workflows across pharmaceutical, clinical, and academic markets globally. The company strengthens its genomics portfolio through advanced molecular testing platforms, sequencing technologies, and strategic investments in precision medicine and diagnostic innovation.
F. Hoffmann La Roche
F. Hoffmann La Roche, headquartered in Basel, Switzerland, was founded in 1896 and is one of the world's leading healthcare companies. Its Roche Diagnostics and sequencing solutions divisions deliver a comprehensive portfolio of PCR (LightCycler, cobas), sequencing, and next-generation sequencing systems alongside companion diagnostics for personalized oncology, infectious disease, and reproductive health applications globally.
Other key players in the market include QIAGEN, Agilent Technologies, Inc., Revvity, Charles River Laboratories, Bio-Rad Laboratories, Inc., BGI Genomics, Color Genomics Inc., and Becton, Dickinson and Company.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Key Questions Answered in the Genomics Market Report
- What was the genomics market value in 2025?
- What is the genomics market forecast outlook for 2026-2035?
- What major factors aid the demand for the genomics market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major genomics market trends?
- Which offering is expected to dominate the market segment?
- Which technology is expected to dominate the market segment?
- Which application is expected to dominate the market segment?
- Which end user is expected to dominate the market segment?
- Who are the key players in the genomics market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$5499 $4949
-
$3299 $2969
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Offering |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
